Transcript
Page 1: The Good, The Bad and The Ugly? Lessons Learned from the Implementation of a Joint Commercialization of Technology Program

Robin Anderson Jon Down

Peter Rachor

University of Portland

Page 2: The Good, The Bad and The Ugly? Lessons Learned from the Implementation of a Joint Commercialization of Technology Program
Page 3: The Good, The Bad and The Ugly? Lessons Learned from the Implementation of a Joint Commercialization of Technology Program
Page 4: The Good, The Bad and The Ugly? Lessons Learned from the Implementation of a Joint Commercialization of Technology Program
Page 5: The Good, The Bad and The Ugly? Lessons Learned from the Implementation of a Joint Commercialization of Technology Program

ViTi, Inc. (TB-8): An exploration of the path to launching a university

biotechnology spinoff and commercializing their lead technology: a technique for diagnosing tuberculosis in young children.

Resorbable Brain Stent to Treat Hydrocephalus; A novel resorbable brain stent designed to increase

the success rate of surgery to correct the rare disorder known as hy-drocephalus, or water on the brain.

APDM – Integrated Solution Targeting Movement Disorders, Specifically Parkinson’s:

APDM ’s OPAL allows for real-time non-invasive monitoring of movements of individuals with Parkinson’s and other movement disorders.

Page 6: The Good, The Bad and The Ugly? Lessons Learned from the Implementation of a Joint Commercialization of Technology Program
Page 7: The Good, The Bad and The Ugly? Lessons Learned from the Implementation of a Joint Commercialization of Technology Program
Page 8: The Good, The Bad and The Ugly? Lessons Learned from the Implementation of a Joint Commercialization of Technology Program
Page 9: The Good, The Bad and The Ugly? Lessons Learned from the Implementation of a Joint Commercialization of Technology Program

Top Related